23andMe's Corporate Minority Round

23andMe raised a round of funding on July 25, 2018. Investors include GlaxoSmithKline.

23andMe is a personal genetics company dedicated to helping individuals understand genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome …

Articles about 23andMe's Corporate Minority Round: